欧洲皮肤病论坛:2020体外光分离置换疗法应用指南更新(第二部分)
欧洲皮肤病论坛(EDF)基于已发表文献和专家共识,更新了2020版体外光分离置换疗法(ECP)应用指南。第二部分涵盖硬皮病、实体器官移植、克罗恩病、儿科患者、特应性皮炎、1型糖尿病、天疱疮、获得性大疱性表皮松解症和糜烂性口腔扁平苔藓。指南为这些适应症提供当前最全面的专家推荐。
要点
- ECP在硬皮病、实体器官移植排斥、克罗恩病等难治性疾病中有应用推荐
- 指南涵盖儿科患者及特应性皮炎、天疱疮、获得性大疱性表皮松解症等皮肤病
- 推荐基于文献和专家共识,为临床实践提供综合指导
核心结论
- 2020版EDF指南基于文献和专家共识,为ECP在多种难治性疾病中的应用提供当前最全面的专家推荐。
研究设计与样本
- 欧洲皮肤病论坛(EDF)组织领域内外专家,采用EDF认可的方法制定指南。
- 所有作者有机会在添加过程中审查每部分内容。
主要发现
- ECP在移植物抗宿主病、系统性硬化症、实体器官移植排斥(肺、心、肝)及炎症性肠病中已获认可。
- 第二部分涵盖硬皮病、实体器官移植、克罗恩病、儿科患者、特应性皮炎、1型糖尿病、天疱疮、获得性大疱性表皮松解症和糜烂性口腔扁平苔藓。
临床怎么用
- 指南为皮肤科医生在多学科环境中使用ECP治疗上述适应症提供专家指导。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Following the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma published in 1983, this technology has received continued use and further recognition for additional earlier as well as refractory forms. After the publication of the first guidelines for this technology in the JEADV in 2014, this technology has maintained additional promise in the treatment of other severe and refractory conditions in a multidisciplinary setting. It has confirmed recognition in well-known documented conditions such as graft-vs.-host disease after allogeneic bone marrow transplantation, systemic sclerosis, solid organ transplant rejection including lung, heart and liver and to a lesser extent inflammatory bowel disease. MATERIALS AND METHODS: In order to further provide recognized expert practical guidelines for the use of this technology for all indications, the European Dermatology Forum (EDF) again proceeded to address these questions in the hands of the recognized experts within and outside the field of dermatology. This was done using the recognized and approved guidelines of EDF for this task. All authors had the opportunity to review each contribution as it was added. RESULTS AND CONCLUSION: These updated 2020 guidelines provide at present the most comprehensive available expert recommendations for the use of extracorporeal photopheresis based on the available published literature and expert consensus opinion. The guidelines were divided into two parts: PART I covers Cutaneous T-cell lymphoma, chronic graft-vs.-host disease and acute graft-vs.-host disease, while PART II will cover scleroderma, solid organ transplantation, Crohn's disease, use of ECP in paediatric patients, atopic dermatitis, type 1 diabetes, pemphigus, epidermolysis bullosa acquisita and erosive oral lichen planus.
引用
- Knobler R, Arenberger P, Arun A, et al. European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 - Part 2. J Eur Acad Dermatol Venereol. 2020. PMID: 32964529. doi:10.1111/jdv.16889
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。